Company: MLTX
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001821586-25-000022
Chunk: 0

Company: MoonLake Immunotherapeutics
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
s

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)September 30, 2025 (Unaudited)December 31, 2024AssetsCurrent assetsCash and cash equivalents$350,736$180,426Short-term marketable debt securities29,743267,601Other receivables4,0222,844Prepaid expenses26,71423,418Total current assets 411,215474,289Non-current assetsOperating lease right-of-use assets1,9112,922Property and equipment, net622722Other non-current assets587—Total non-current assets3,1203,644Total assets $414,335 $477,933Liabilities and EquityCurrent liabilitiesTrade and other payables$25,282 $8,992 Accrued expenses and other current liabilities21,58712,099Short-term portion of operating lease liabilities1,4991,372Total current liabilities 48,36822,463Non-current liabilitiesLong-term debt73,741—Long-term portion of operating lease liabilities4861,458Pension liability549621Total non-current liabilities74,7762,079Total liabilities123,14424,542Commitments and contingencies (Note 16)Shareholders' equityClass A Ordinary Shares: $0.0001 par value per share; 500,000,000 shares authorized; 63,704,544 shares issued and outstanding as of September 30, 2025; 63,077,431 shares issued and outstanding as of December 31, 202466Class C Ordinary Shares: $0.0001 par value per share; 100,000,000 shares authorized; 526,178 shares issued and outstanding as of September 30, 2025; 841,269 shares issued and outstanding as of December 31, 2024——Additional paid-in capital689,108677,415Accumulated deficit(400,486)(235,593)Accumulated other comprehensive income2784,997Total shareholders’ equity 288,906446,825Noncontrolling interests2,2856,566Total equity291,191453,391Total liabilities and equity$414,335$477,933

The accompanying Notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

2

MOONLAKE IMMUNOTHERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS(Un